There is some controversy about a new pharmaceutical drug to treat osteoporosis in post-menopausal women at high risk of fracture. It is called Romosozumab or Everity.
According to this MIMS article, some doctors in England the Wales are calling on NICE to reverse the decision not to approve this new drug, which is already approved in Northern Ireland and Scotland. It is, apparently, the first new osteoporosis drug to come to the market in over ten years.
So what is wrong with the drug? Why has NICE not approved the drug for use?
This is what the Drugs.com website tells us about the adverse drug reactions it is known to cause.
"Warning:
* Potential Risk of Myocardial Infarction, Stroke and Cardiovascular Death.
* Romosozumab-aqqg may increase the risk of myocardial infarction, stroke, and cardiovascular death.
* Romosozumab-aqqg should not be initiated in patients who have had a myocardial infarction or stroke within the preceding year.
* Consider whether the benefits outweigh the risks in patients with other cardiovascular risk factors.
If a patient experiences a myocardial infarction or stroke during therapy, romosozumab-aqqg should be discontinued."
So why do these doctors disagree with the NICE decision, and want to use the new drug with their patients?
It can only be assumed that these doctors do not mind giving their patients drugs that cause heart disease, and death. Perhaps they have nothing better to offer, and that anything is better than nothing.
Whatever, it certainly demonstrates that the precautionary principle, and the Hippocratic oath, "first do no harm", is something that these conventional medical doctors do not understand.
And I expect you thought that doctors have your best interests at heart?
